Zofenopril is a cost-effective treatment for patients with left ventricular systolic dysfunction following acute myocardial infarction: a pharmacoeconomic analysis of the SMILE-4 study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.